Building on his lab’s expertise in human liver pathogens, Princeton’s Alexander Ploss and his team have pioneered new screening platforms and new methods to evaluate therapeutic candidates against hepatitis B and E viruses, which cause life-threatening infections. https://www.princeton.edu/news/2019/12/31/identifying-new-drugs-cure-hepatitis-b-and-e-virus-infection